Scipher Medicine: John Strumbos
Scipher Medicine has appointed John Strumbos as its chief financial officer. Strumbos has over 20 years of capital markets, finance, and strategy experience in the life science industry. Prior to joining Scipher, he was VP of finance and strategy at Immunovant. Before that, he served in a variety of life science investing roles at Weiss Multi-Strategy Advisors, Buysydr, and Citadel. While working for Goldman Sachs and Morgan Stanley, he advised life science companies on capital markets deals totaling $2 billion in gross proceeds and mergers and acquisitions totaling $7 billion in enterprise value. He holds a PhD in neuroscience from Yale University, an MBA from the Yale School of Management, and a BA in neuroscience from Columbia University.